EAST RUTHERFORD, N.J., May 15, 2017 (GLOBE NEWSWIRE) — Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that Steven Klosk, President and Chief Executive Officer, will present at the 2017 UBS Global Healthcare Conference on May 22, 2017 at 10:30 a.m. EDT in New York …
The post Cambrex to Present at the 2017 UBS Global Healthcare Conference appeared first on ForexTV.
May 15, 2017 at 11:33PM
from Nasdaq NewsFeed
No comments:
Post a Comment